Company Filing History:
Years Active: 1981
Title: Maija K Koivisto: Innovator in Antihypertensive Drug Development
Introduction
Maija K Koivisto is a notable inventor based in Helsinki, Finland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive medications. Her innovative work has led to advancements that benefit patients suffering from hypertension.
Latest Patents
Koivisto holds a patent for a method of producing 6,7-dimethoxy-4-amino-2-[4-(2-furoyl)-1-piperazinyl] quinazoline hydrochloride, commonly known as prazosine hydrochloride. This improved method involves reacting methyl-N-(3,4-dimethoxy-6-cyano-phenyl)-[4-(2-furoyl)-1-piperazinyl] thioformamidate with a large excess of ammonium chloride. This innovation enhances the efficiency of producing this important antihypertensive drug.
Career Highlights
Koivisto is associated with Orion-yhtyma Oy, a prominent company in the pharmaceutical industry. Her work at Orion has allowed her to focus on research and development, contributing to the advancement of medical treatments. With her expertise, she has played a crucial role in the innovation of new therapeutic solutions.
Collaborations
Throughout her career, Koivisto has collaborated with esteemed colleagues, including Erkki J Honkanen and Aino K Pippuri. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.
Conclusion
Maija K Koivisto is a distinguished inventor whose work in antihypertensive drug development has made a significant impact in the pharmaceutical field. Her innovative methods and collaborations continue to pave the way for advancements in medical treatments.